AISLING CAPITAL III LP Insider Trading $LOXO Loxo Oncology, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for AISLING CAPITAL III LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AISLING CAPITAL III LP. AISLING CAPITAL III LP is 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in T2 Biosystems, Inc. ($TTOO) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Loxo Oncology, Inc. ($LOXO).
AISLING CAPITAL III LP in Loxo Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of AISLING CAPITAL III LP: 10% Owner
Holdings: 2,038,920 shares
Current Value: $80,945,124
Latest Transaction: Jul 12 2018
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of AISLING CAPITAL III LP in Loxo Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGRX, LOXO, SYRS, TTOO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12 2018 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Sell | S | 179.43 | 1,400,000 | 251,202,000 | 2,038,920 | 3.4 M to 2 M (-40.71 %) |
| Dec 20 2017 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Sell | S | 80.50 | 250,000 | 20,125,000 | 3,438,920 | 3.7 M to 3.4 M (-6.78 %) |
| Nov 27 2017 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Sell | S | 75.00 | 500,000 | 37,500,000 | 3,688,920 | 4.2 M to 3.7 M (-11.94 %) |
| Jan 12 2017 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 31.00 | 160,000 | 4,960,000 | 4,188,920 | 4 M to 4.2 M (+3.97 %) |
| May 19 2016 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 21.50 | 232,558 | 4,999,997 | 4,028,920 | 3.8 M to 4 M (+6.13 %) |
| Dec 15 2015 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 27.50 | 200 | 5,500 | 3,796,362 | 3.8 M to 3.8 M (+0.01 %) |
| Nov 19 2015 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 26.50 | 265,000 | 7,022,500 | 3,796,182 | 3.5 M to 3.8 M (+7.50 %) |
| Nov 16 2015 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 27.47 | 1,955 | 53,704 | 3,531,182 | 3.5 M to 3.5 M (+0.06 %) |
| Nov 16 2015 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 27.65 | 76,714 | 2,121,319 | 3,529,207 | 3.5 M to 3.5 M (+2.22 %) |
Page: 1